Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Familial Alcoholism Vulnerability

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hartford Hospital, Hartford, Connecticut, United States
Contact: Study coordinator (Godfrey D Pearlson, MD) · godfrey.pearlson@hhchealth.org · 203-737-3416
Contact: Principal Investigator (Godfrey D Pearlson, MD)

Study leads

Godfrey D Pearlson, MD
Principal Investigator
Yale University

View source on ClinicalTrials.gov